Calamos Advisors’s Exact Sciences EXAS Stock Holding History

Calamos Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-34,650	Closed	-$623K	–	662
2015 Q3	$623K	Buy	+34,650	New	+$796K	﹤0.01%	574

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Calamos Advisors's EXAS Position: Q4 2015 in Review

Calamos Advisors sold out of Exact Sciences (EXAS) in Q4 2015, closing a stake of 34,650 shares — an estimated $623K sold.

Calamos Advisors first reported a position in EXAS in Q3 2015 and held it in 1 quarter. The position peaked at $623K in Q3 2015. 183 funds tracked by Wall St. Rank hold EXAS as of Q4 2015.

Calamos Advisors reported no remaining Exact Sciences position as of Q4 2015 after selling out during the quarter.
Calamos Advisors sold 34,650 Exact Sciences shares in Q4 2015, an estimated $623K.
Calamos Advisors first reported a position in Exact Sciences in Q3 2015 and held it in 1 quarter.
Calamos Advisors's Exact Sciences position peaked at $623K in Q3 2015.
183 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2015.

Based on Calamos Advisors's 13F filing for Q4 2015, filed 5 Feb 2016.